p21	O
delays	O
tumor	B-Cancer
onset	O
by	O
preservation	O
of	O
chromosomal	B-Cellular_component
stability	O
.	O

The	O
p53	O
protein	O
suppresses	O
tumorigenesis	O
by	O
initiating	O
cellular	B-Cell
functions	O
such	O
as	O
cell	B-Cell
cycle	O
arrest	O
and	O
apoptosis	O
in	O
response	O
to	O
DNA	O
damage	O
.	O

A	O
p53	O
mutant	O
,	O
p53R172P	O
,	O
which	O
is	O
deficient	O
for	O
apoptosis	O
but	O
retains	O
a	O
partial	O
cell	B-Cell
cycle	O
arrest	O
function	O
,	O
delays	O
tumor	B-Cancer
onset	O
in	O
mice	O
.	O

Remarkably	O
,	O
lymphomas	B-Cancer
arising	O
in	O
Trp53	O
(	O
515C	O
/	O
515C	O
)	O
mice	O
(	O
encoding	O
p53R172P	O
)	O
retain	O
stable	O
genomes	O
.	O

Given	O
the	O
dominant	O
role	O
of	O
p21	O
in	O
p53	O
cell	B-Cell
cycle	O
control	O
,	O
we	O
crossed	O
Trp53	O
(	O
515C	O
/	O
515C	O
)	O
mice	O
onto	O
a	O
p21	O
-	O
null	O
background	O
to	O
determine	O
whether	O
p21	O
was	O
required	O
for	O
maintaining	O
chromosomal	B-Cellular_component
stability	O
and	O
delaying	O
tumor	B-Cancer
onset	O
.	O

Loss	O
of	O
p21	O
completely	O
abolished	O
the	O
cell	B-Cell
cycle	O
arrest	O
function	O
of	O
p53R172P	O
and	O
accelerated	O
tumor	B-Cancer
onset	O
in	O
Trp53	O
(	O
515C	O
/	O
515C	O
)	O
mice	O
.	O

Cytogenetic	O
examination	O
of	O
Trp53	O
(	O
515C	O
/	O
515C	O
)	O
p21	O
(	O
-	O
/	O
-	O
)	O
sarcomas	B-Cancer
and	O
lymphomas	B-Cancer
revealed	O
aneuploidy	O
and	O
chromosomal	B-Pathological_formation
aberrations	I-Pathological_formation
that	O
were	O
absent	O
in	O
Trp53	O
(	O
515C	O
/	O
515C	O
)	O
malignancies	B-Cancer
.	O

Thus	O
,	O
p21	O
coupled	O
p53	O
-	O
dependent	O
checkpoint	O
control	O
and	O
preservation	O
of	O
chromosomal	B-Cellular_component
stability	O
,	O
and	O
cooperated	O
with	O
apoptosis	O
in	O
suppressing	O
tumor	B-Cancer
onset	O
in	O
mice	O
.	O

